Olaparib (AZD2281) is a potent, orally active PARP1/2 inhibitor (IC50 = 5 and 1 nM, respectively) and an autophagy activator. It enhances cancer cell death by blocking BER and is effective alone or in combination with alkylating agents. Reagent grade, for research purpose.
Usually ships within 24 hours.